A detailed history of Northern Trust Corp transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 209,820 shares of BIO stock, worth $73.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
209,820
Previous 248,728 15.64%
Holding current value
$73.5 Million
Previous $67.9 Million 3.34%
% of portfolio
0.01%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$263.97 - $344.64 $10.3 Million - $13.4 Million
-38,908 Reduced 15.64%
209,820 $70.2 Million
Q2 2024

Aug 14, 2024

SELL
$268.26 - $339.48 $1.29 Million - $1.63 Million
-4,805 Reduced 1.9%
248,728 $67.9 Million
Q1 2024

May 14, 2024

BUY
$304.11 - $351.99 $346,077 - $400,564
1,138 Added 0.45%
253,533 $87.7 Million
Q4 2023

Feb 13, 2024

SELL
$269.37 - $365.04 $2.5 Million - $3.38 Million
-9,265 Reduced 3.54%
252,395 $81.5 Million
Q3 2023

Nov 13, 2023

BUY
$350.25 - $422.63 $5.89 Million - $7.1 Million
16,808 Added 6.86%
261,660 $93.8 Million
Q2 2023

Aug 11, 2023

SELL
$359.49 - $486.4 $5.92 Million - $8.01 Million
-16,459 Reduced 6.3%
244,852 $92.8 Million
Q1 2023

May 15, 2023

BUY
$418.69 - $503.0 $778,344 - $935,077
1,859 Added 0.72%
261,311 $125 Million
Q4 2022

Feb 13, 2023

BUY
$351.71 - $456.01 $3.86 Million - $5 Million
10,972 Added 4.42%
259,452 $109 Million
Q3 2022

Nov 14, 2022

SELL
$412.59 - $563.26 $1.97 Million - $2.69 Million
-4,770 Reduced 1.88%
248,480 $104 Million
Q2 2022

Aug 12, 2022

SELL
$463.67 - $597.16 $462,278 - $595,368
-997 Reduced 0.39%
253,250 $125 Million
Q1 2022

May 13, 2022

SELL
$524.57 - $735.42 $125,372 - $175,765
-239 Reduced 0.09%
254,247 $143 Million
Q4 2021

Feb 08, 2022

SELL
$708.84 - $794.68 $4.17 Million - $4.67 Million
-5,876 Reduced 2.26%
254,486 $192 Million
Q3 2021

Nov 15, 2021

SELL
$657.71 - $825.77 $9.05 Million - $11.4 Million
-13,766 Reduced 5.02%
260,362 $194 Million
Q2 2021

Aug 13, 2021

BUY
$576.64 - $649.04 $9.9 Million - $11.1 Million
17,163 Added 6.68%
274,128 $177 Million
Q1 2021

May 12, 2021

SELL
$547.01 - $662.35 $798,634 - $967,031
-1,460 Reduced 0.56%
256,965 $147 Million
Q4 2020

Feb 11, 2021

BUY
$510.68 - $643.45 $855,899 - $1.08 Million
1,676 Added 0.65%
258,425 $151 Million
Q3 2020

Nov 16, 2020

SELL
$454.43 - $535.6 $304,468 - $358,852
-670 Reduced 0.26%
256,749 $132 Million
Q2 2020

Aug 14, 2020

BUY
$334.87 - $493.06 $7.14 Million - $10.5 Million
21,322 Added 9.03%
257,419 $116 Million
Q1 2020

May 14, 2020

BUY
$320.01 - $409.07 $2.02 Million - $2.58 Million
6,319 Added 2.75%
236,097 $82.8 Million
Q4 2019

Feb 14, 2020

BUY
$319.73 - $374.2 $11.2 Million - $13.1 Million
34,967 Added 17.95%
229,778 $85 Million
Q3 2019

Nov 13, 2019

BUY
$304.55 - $345.24 $1.27 Million - $1.45 Million
4,186 Added 2.2%
194,811 $64.8 Million
Q2 2019

Aug 13, 2019

SELL
$286.93 - $312.59 $860 - $937
-3 Reduced -0.0%
190,625 $59.6 Million
Q1 2019

May 13, 2019

BUY
$224.3 - $317.41 $954,620 - $1.35 Million
4,256 Added 2.28%
190,628 $58.3 Million
Q4 2018

Feb 12, 2019

BUY
$220.1 - $309.0 $182,903 - $256,779
831 Added 0.45%
186,372 $43.3 Million
Q3 2018

Nov 14, 2018

SELL
$289.28 - $326.15 $391,106 - $440,954
-1,352 Reduced 0.72%
185,541 $58.1 Million
Q2 2018

Sep 18, 2018

SELL
$244.1 - $303.88 $471,357 - $586,792
-1,931 Reduced 1.02%
186,893 $53.9 Million
Q2 2018

Aug 14, 2018

BUY
$244.1 - $303.88 $249,714 - $310,869
1,023 Added 0.54%
188,824 $54.5 Million
Q1 2018

May 09, 2018

BUY
$233.97 - $274.11 $222,037 - $260,130
949 Added 0.51%
187,801 $47 Million
Q4 2017

Feb 14, 2018

SELL
$216.94 - $271.3 $4.24 Million - $5.3 Million
-19,539 Reduced 9.47%
186,852 $44.6 Million
Q3 2017

Nov 13, 2017

BUY
$212.27 - $242.28 $43.8 Million - $50 Million
206,391
206,391 $45.9 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.63B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.